Olema Pharmaceuticals Inc (OLMA)

01:16 AM

Jim Cramer on Olema Pharmaceuticals: "Too risky for me" - MSN

01:16 AM

Apr 20, 2026

Olema Pharmaceuticals expands workforce to drive oncology innovation - Traders Union

Apr 20, 2026

Apr 20, 2026

Piper Sandler Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $40 - Moomoo

Apr 20, 2026

Apr 19, 2026

Olema Pharmaceuticals (NASDAQ:OLMA) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat

Apr 19, 2026

Apr 18, 2026

Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting - Sahm

Apr 18, 2026

Apr 17, 2026

Olema Pharmaceuticals (OLMA) Unveils New Data on Palazestrant - GuruFocus

Apr 17, 2026

Apr 17, 2026

Olema Pharmaceuticals unveils new preclinical data ahead of AACR2026 presentation - Traders Union

Apr 17, 2026

Apr 17, 2026

Breast cancer drug pair shows synergy as Olema readies Phase 3 data - Stock Titan

Apr 17, 2026

Apr 17, 2026

OLMA Forecast, Price Target & Analyst Ratings | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) - ChartMill

Apr 17, 2026

Apr 15, 2026

Early development of Olema and Aurigene’s OP-3136 for breast cancer - BioWorld News

Apr 15, 2026

Apr 14, 2026

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat

Apr 14, 2026

Apr 13, 2026

Rate Cut: Is Olema Pharmaceuticals Inc forming bullish engulfing patterns2026 Setups & Stock Portfolio Risk Management - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Olema Pharmaceuticals (NASDAQ:OLMA) Raised to "Sell" at Wall Street Zen - MarketBeat

Apr 11, 2026

Apr 10, 2026

Olema Pharmaceuticals posts new leadership role to advance clinical study compliance - Traders Union

Apr 10, 2026

Apr 10, 2026

Aurigene Oncology and Olema Pharmaceuticals patent KAT6A degradation inducers - BioWorld News

Apr 10, 2026

Apr 09, 2026

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% HigherHere's What Happened - MarketBeat

Apr 09, 2026

Apr 06, 2026

Sentiment Review: Is Olema Pharmaceuticals Inc stock trending bullish2026 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Market Review: How does Olema Pharmaceuticals Inc perform in inflationary periods2026 Institutional Moves & Daily Growth Stock Tips - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

SG Americas Securities LLC Purchases Shares of 69,382 Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Apr 06, 2026

Apr 03, 2026

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 03, 2026

Apr 02, 2026

Olema oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Apr 02, 2026

Apr 02, 2026

OLMA SEC FilingsOlema Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 01, 2026

OLMA Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 01, 2026

Mar 31, 2026

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 8.4%Still a Buy? - MarketBeat

Mar 31, 2026

Mar 30, 2026

Targets Report: How does Olema Pharmaceuticals Inc perform in inflationary periodsMarket Sentiment Review & Technical Buy Zone Confirmation - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

A Look At Olema Pharmaceuticals (OLMA) Valuation After Earnings And New Shelf Registration Filing - Sahm

Mar 30, 2026

Mar 30, 2026

Hennion & Walsh Asset Management Inc. Increases Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat

Mar 30, 2026

Mar 29, 2026

Olema Pharmaceuticals Inc at Citi Oncology Leadership Summit (Virtual) Transcript - GuruFocus

Mar 29, 2026

Mar 28, 2026

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Mar 28, 2026

Mar 27, 2026

Wolfe Research initiates coverage of Olema Pharmaceuticals (OLMA) with peer perform recommendation - MSN

Mar 27, 2026

Mar 27, 2026

Wolfe Research Initiates Coverage on Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat

Mar 27, 2026

Mar 26, 2026

Olema Pharmaceuticals seeks senior director to lead accounting operations and financial reporting - Traders Union

Mar 26, 2026

Mar 26, 2026

Buybacks Report: Will Olema Pharmaceuticals Inc outperform its industry peers2026 Key Highlights & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Aug PostEarnings: What are analysts price targets for Olema Pharmaceuticals IncWeekly Stock Report & Reliable Intraday Trade Alerts - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

Oppenheimer maintains Olema Pharmaceuticals (OLMA) outperform recommendation - MSN

Mar 24, 2026

Mar 24, 2026

Jim Cramer on Olema Pharmaceuticals: “Too Risky for Me” - Insider Monkey

Mar 24, 2026

Mar 23, 2026

Olema Shelf Registration Raises Questions On Dilution And Funding Flexibility - Yahoo Finance

Mar 23, 2026

Mar 22, 2026

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? - AOL.com

Mar 22, 2026

Mar 20, 2026

Invus entities disclose 4.5% stake in Olema (OLMA) on Schedule 13G - Stock Titan

Mar 20, 2026

Mar 20, 2026

Jefferies Adjusts Price Target for Olema Pharmaceuticals (OLMA) - GuruFocus

Mar 20, 2026

Mar 20, 2026

Olema Pharmaceuticals (OLMA) loses 33.4% in 4 weeks, here's why a trend reversal may be around the corner - MSN

Mar 20, 2026

Mar 20, 2026

Jefferies Adjusts Price Target for Olema Pharmaceuticals (OLMA) | OLMA Stock News - GuruFocus

Mar 20, 2026

Mar 19, 2026

Olema Pharmaceuticals (OLMA) Is Down 6.7% After Posting Wider Losses And Filing New Stock Shelf - simplywall.st

Mar 19, 2026